Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,810 | 44,329 | 35,420 | 34,953 | 25,495 |
| Receivables | 83,278 | 67,703 | 68,324 | 69,478 | 66,650 |
| Other current assets | 53,961 | 35,135 | 30,063 | 27,947 | 23,140 |
| TOTAL | $180,590 | $151,224 | $138,065 | $137,394 | $122,246 |
| Non-Current Assets | |||||
| PPE Net | 2,218,676 | 2,106,880 | 2,005,299 | 1,979,382 | 1,864,790 |
| Investments And Advances | 275,826 | 249,665 | 246,450 | 199,994 | 90,643 |
| Intangibles | 22,429 | 22,973 | 23,517 | 23,950 | 24,383 |
| Other Non-Current Assets | 22,937 | 24,389 | 14,797 | 15,437 | 8,642 |
| TOTAL | $2,539,868 | $2,403,907 | $2,290,063 | $2,218,763 | $1,988,458 |
| Total Assets | $2,720,458 | $2,555,131 | $2,428,128 | $2,356,157 | $2,110,704 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 159,599 | 168,928 | 132,049 | 133,322 | 112,587 |
| Accounts payable and accrued liabilities | 190,788 | 140,946 | 102,091 | 200,619 | 79,831 |
| Accrued Expenses | 17,206 | 11,245 | 15,706 | 13,540 | 15,068 |
| TOTAL | $375,119 | $328,367 | $257,657 | $355,842 | $214,689 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,679,492 | 1,567,339 | 1,570,773 | 1,450,588 | 1,364,079 |
| Deferred Revenues | 7,526 | 7,248 | 7,811 | 8,361 | 7,203 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 1,169 |
| TOTAL | $1,716,591 | $1,603,944 | $1,606,626 | $1,501,781 | $1,416,459 |
| Total Liabilities | $2,091,710 | $1,932,311 | $1,864,283 | $1,857,623 | $1,631,147 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,306 | 20,494 | 20,491 | 19,268 | 19,247 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 433,906 | 414,757 | 397,640 | 361,077 | 343,490 |
| Other shareholders' equity | 48,630 | -5,812 | -6,122 | -6,390 | -7,087 |
| TOTAL | $628,748 | $622,820 | $563,845 | $498,534 | $479,557 |
| Total Liabilities And Equity | $2,720,458 | $2,555,131 | $2,428,128 | $2,356,157 | $2,110,704 |